dapsone has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Morris, LM | 1 |
| Lewis, HA | 1 |
| Cornelius, LA | 1 |
| Chen, DY | 1 |
| Rosman, IS | 1 |
| Schmidgen, MI | 1 |
| Butsch, F | 1 |
| Schadmand-Fischer, S | 1 |
| Steinbrink, K | 1 |
| Grabbe, S | 1 |
| Weidenthaler-Barth, B | 1 |
| Loquai, C | 1 |
| Kyllo, RL | 1 |
| Parker, MK | 1 |
| Rosman, I | 1 |
| Musiek, AC | 1 |
1 review available for dapsone and Malignant Melanoma
| Article | Year |
|---|---|
Ipilimumab-associated Sweet syndrome in a patient with high-risk melanoma.
Topics: Aged; Antibodies, Monoclonal; Biopsy, Needle; Chemotherapy, Adjuvant; Dapsone; Female; Follow-Up Stu | 2014 |
1 trial available for dapsone and Malignant Melanoma
| Article | Year |
|---|---|
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.
Topics: Antibodies, Monoclonal, Humanized; Complement C3; Dapsone; Dose-Response Relationship, Drug; Double- | 2017 |
1 other study available for dapsone and Malignant Melanoma
| Article | Year |
|---|---|
Neutrophil-predominant bullous pemphigoid induced by checkpoint inhibitors: A case series.
Topics: Aged; Antimalarials; Dapsone; Drug Eruptions; Drug Therapy, Combination; Glucocorticoids; Humans; Im | 2020 |